🚨📣 #Patients with #LungCancer & #CareGivers, join us TOMORROW morning, Sat Nov 18th for a FREE "#CancerEducation Symposium" (In-Person & Online) Mayo Clinic Comprehensive Cancer Center Mayo Clinic Florida #LungCancer 2023: AN ERA OF #HOPE PLZ SHARE Registration link👇🏼 CE.Mayo.Edu/LungCancer2023

To those who joined us in November for the #ILCS23, don't forget to download your certificate of attendance with accreditation from the EACCME! Simply sign in and download your certificate ⬇️

Finally at the end of training and planning to apply/ interviewing for academic jobs? Our article on the forest and the trees of an academic job search is finally out Neurology Journal. Includes approach for IMGs. P.S. Supplementary data Link: neurology.org/doi/pdf/10.121…

1. Pumped to share that our article “Consolidation Osimertinib versus Durvalumab versus Observation following Concurrent Chemoradiation in Unresectable EGFR-Mutant Non-Small-Cell Lung Cancer: A Multicenter Retrospective Cohort Study” is now out in JTO! jto.org/article/S1556-…

What are the current and future treatment options for those with #SCLC? 🫁 Explore the topic in Kaushal Parikh's keynote talk from the lastest #ILCS23 meeting. Watch and download the full presentation online ⬇️

Lung Cancer 360, your new go-to destination for online multidisciplinary education, provides access to a wide range of CME & non-CME education resources. One of the educational activities you will find, is the collection of IASLC Webinars. bit.ly/IASLC-LC360 #LungCancer360

I have a new favorite medical school 🫡🤯 Balazs Halmos Sam Rosner $1 Billion Donation Will Provide Free Tuition at a Bronx Medical School nytimes.com/2024/02/26/nyr…

🚨The future of #ThoracicOncology is in great hands! My co-chair colleague Dr Christian Rolfo, myself, great faculty mentors, & #IASLC staff are honored to kick off the: “2024 global IASLC #Academy.” Welcome to an outstanding group of #EarlyCareer #Physicians & #Researchers.

Haha, now this is cute. HarPar33 Dr. Bhavik Panchal Mrinal Patnaik

Uncommon EGFR mutations (non T790M and ex20) and response to EGFR TKIs Open access link: jto.org/article/S1556-…

The landscape of #lungcancer therapy is swiftly advancing w/the introduction of numerous novel drugs & treatment approaches in the past year. This #IASLC Webinar will go over research findings presented at the recent #TTLC24 conference. Register Now: bit.ly/TTLC24Web #LCSM

Best of TTLC webinar is live now!!! Come join us! Kaushal Parikh Amit Kulkarni Antoinette Wozniak. #IASLC #LCSM

Nice read by Alfredo Addeo MD, Giuseppe Banna and team!

Register now for OncLive.com State of the Science Treatment Crossroads: Lung Cancer, discussing targeted treatment, research and more with Mayo Clinic medical oncologists and co-chairs Drs. Kaushal Parikh & Konstantinos Leventakos. Kostas Leventakos Kaushal Parikh bit.ly/3KaKa1U

Limited Spaces available for this curated program. Stellar faculty including Amit Kulkarni

Probably one of the best meetings for scientific stimulation

Go India!!! Jeetega bhai jeetega, India jeetega!!

Thank you for highlighting our work Stephen V Liu, MD We provide further evidence to support the use of lorlatinib especially in patients with V3 fusion or p53 mutations. CROWN had a ~60 month PFS for both groups.

Thank you for the shout out, Jarushka Naidoo

Kaushal Parikh, MBBS, highlights how PD-L1 expression affects treatment decision-making in the absence of other targetable mutations or prognostic indicators in non–small cell lung cancer. Kaushal Parikh Mayo Clinic Comprehensive Cancer Center #lcsm #oncology #MedTwitter onclive.com/view/pd-l1-exp…